Stereotaxis (STXS) Non Operating Interest Expenses (2010 - 2019)
Stereotaxis' (STXS) quarterly Non Operating Interest Expenses came in at -$31810.0 in Q2 2019, down 617.91% year-over-year from $6142.0 in Q2 2018, and down 92.02% quarter-over-quarter from -$16566.0 in Q1 2019.
Analysis
Stereotaxis (STXS) Non Operating Interest Expenses (2010 - 2019) Analysis & Trends
Stereotaxis (STXS) has reported Non Operating Interest Expenses for 10 consecutive years, with -$31810.0 the latest figure, recorded in Q2 2019.
- On a quarterly basis, Non Operating Interest Expenses fell 617.91% year-over-year to -$31810.0 in Q2 2019; TTM through Jun 2019 was -$62566.0, a 152.87% decrease from a year earlier, with the FY2018 full-year figure at $16566.0, down 90.79% from the prior year.
- Non Operating Interest Expenses was -$31810.0 for Q2 2019 at Stereotaxis, down from -$16566.0 in the prior quarter.
- Over five years, Non Operating Interest Expenses peaked at $829788.0 in Q1 2015 and troughed at -$31810.0 in Q2 2019.
- A 5-year average of $328643.7 and a median of $43792.5 in 2017 frame the typical range for Non Operating Interest Expenses.
- Across the five-year window, Non Operating Interest Expenses surged 168.43% in 2017 and sank 617.91% in 2019, its largest moves.
- Over 5 years, Non Operating Interest Expenses stood at $823287.0 in 2015, then sank by 97.99% to $16581.0 in 2016, then surged by 168.43% to $44508.0 in 2017, then sank by 137.53% to -$16705.0 in 2018, then slumped by 90.42% to -$31810.0 in 2019.
- The last three Non Operating Interest Expenses figures came in at -$31810.0 (Q2 2019), -$16566.0 (Q1 2019), and -$16705.0 (Q4 2018), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 186.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 141.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 96.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -53.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 15.80 Mn |
| 10 | Stereotaxis | 129.55 Mn | 114.93 Mn | 3.79 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2019 | -31,810.00 |
| Mar 31, 2019 | -16,566.00 |
| Dec 31, 2018 | -16,705.00 |
| Sep 30, 2018 | 2,515.00 |
| Jun 30, 2018 | 6,142.00 |
| Mar 31, 2018 | 24,615.00 |
| Dec 31, 2017 | 44,508.00 |
| Sep 30, 2017 | 43,077.00 |
| Jun 30, 2017 | 42,775.00 |
| Mar 31, 2017 | 49,483.00 |
| Dec 31, 2016 | 16,581.00 |
| Sep 30, 2016 | 818,738.00 |
| Jun 30, 2016 | 829,046.00 |
| Mar 31, 2016 | 819,019.00 |
| Dec 31, 2015 | 823,287.00 |
| Sep 30, 2015 | 815,071.00 |
| Jun 30, 2015 | 816,023.00 |
| Mar 31, 2015 | 829,788.00 |
| Dec 31, 2014 | 829,458.00 |
| Sep 30, 2014 | 834,224.00 |